Kiora Pharmaceuticals, Inc. (KPRX) NASDAQ
2.54
+0.1(+4.10%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.54
+0.1(+4.10%)
Currency In USD
| Market Cap | 8.21M |
| Enterprise Value | -119,927 |
| P/E Ratio | -0.98 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.66 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.18 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.45 |
| Return On Equity | -0.51 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -24,801 |
| EBITDA | -9.43M |
| Net Income | -10.84M |
| Diluted EPS | -2.64 |
| Total Cash | 17.09M |
| Total Cash/Share | 4.1 |
| Total Debt | 368,259 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 5.99 |
| Book Value Per Share | 3.87 |
| 52-Week Change | -22.09 |
| 52-Week High | 4.18 |
| 52-Week Low | 1.77 |
| Moving Average 50 Days | 2.19 |
| Moving Average 200 Days | 2.35 |
| Average Volume | 509,198 |
| Shares Outstanding | 3.95M |
| % Held by Institutions | 1.12 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:9 |
| Last Split Date | June 11, 2024 |